FDA Approves Botulism Countermeasure

CDC began developing Botulism Antitoxin Heptavalent about 10 years ago, and it became one of the first medical countermeasures approved for advanced development and procurement under Project BioShield, in 2006.

HHS has approved Botulism Antitoxin Heptavalent, the agency's Assistant Secretary for Preparedness and Response Dr. Nicole Lurie announced March 22, saying U.S. preparedness "took another important step today with the U.S. Food and Drug Administration's approval of Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)-(Equine), the only product to neutralize all known botulinum nerve toxin serotypes that cause botulism. Botulinum nerve toxins are among the most potent toxins, and if patients are left untreated, the toxins may cause muscular paralysis and can lead to death. This new antitoxin is the only product available for the treatment of botulism in adults and children older than 1 year of age. It is also the only one available to treat infant botulism caused by nerve toxins other than types A and B. My office's Biomedical Advanced Research and Development Authority is proud to have been a part of the development of this drug, which addresses an urgent medical need and a national bioterrorism threat.

Her statement said about 100 people in the United States are hospitalized with botulism per year from eating improperly preserved food or by absorbing the toxin secreted by bacteria that have infected a wound or the intestine. "Importantly, botulinum nerve toxins also can be used as a bioweapon. A biological terrorism event with botulinum nerve toxins would require a rapid health response with potentially little time to determine which botulism toxin was used. This new drug can be used to treat all known botulinum nerve toxin serotypes and can be used quickly in this type of public health emergency," she explained.

CDC began developing Botulism Antitoxin Heptavalent about 10 years ago, and it became one of the first medical countermeasures approved for advanced development and procurement under Project BioShield, in 2006. "Today's approval demonstrates how well this program works in moving emergency medical countermeasures from initial research and development to approval, so the products are available in our nation's moment of need," Lurie said.

It is the first botulism product approved by the FDA and the second antitoxin to address a bioterrorism threat under Project BioShield and approved by FDA.

Download Center

HTML - No Current Item Deck
  • Free Safety Management Software Demo

    IndustrySafe Safety Management Software helps organizations to improve safety by providing a comprehensive toolset of software modules to help businesses identify trouble spots; reduce claims, lost days, OSHA fines; and more.

  • The Top 5 Safety and Technology Trends to Watch

    Get the latest on trends you can expect to hear more about in 2019, including continued growth of mobile safety applications, wearable technology, and smart PPE; autonomous vehicles; pending OSHA recordkeeping rulemaking; and increased adoption of international safety standard, ISO 45001.

  • Analyze Incident Data

    Collect relevant incident data, analyze trends, and generate accurate regulatory reports, including OSHA 300, 300A, and 301 logs, through IndustrySafe’s extensive incident reporting and investigation module.

  • Safety Training 101

    When it comes to safety training, no matter the industry, there are always questions regarding requirements and certifications. We’ve put together a guide on key safety training topics, requirements for certifications, and answers to common training questions.

  • Conduct EHS Inspections and Audits

    Record and manage your organization’s inspection data with IndustrySafe’s Inspections module. IndustrySafe’s pre-built forms and checklists may be used as is, or can be customized to better suit the needs of your organization.

  • Industry Safe
comments powered by Disqus

OH&S Digital Edition

  • OHS Magazine Digital Edition - January 2019

    January / February 2019

    Featuring:

    • PREVENTING ERRORS
      Production vs. Safety 
    • EMERGENCY SHOWERS & EYEWASH
      Meeting the Requirements for Emergency Equipment
    • CONSTRUCTION SAFETY
      The State of Contractor Safety
    • FOOT PROTECTION
      The Three Keys to Effective Chemical Management
    View This Issue